You’re invited to join Cencora’s virtual Product Showcase! Be the first to know as Cencora leaders announce new solutions purpose-built to support our customers' and partners' evolving needs, unveil major enhancements to existing products, and spotlight innovative partnerships driving the future of healthcare. Register to attend on December 4th: https://bit.ly/49pGAPn
About us
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 51,000 worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $290 billion in annual revenue.
- Website
-
https://www.cencora.com/
External link for Cencora
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Type
- Public Company
- Specialties
- pharmaceutical distribution, supply chain management, pharmaceutical service, product commercialization, healthcare logistics, provider efficiency technologies, consulting, and business coaching
Employees at Cencora
Updates
-
“Training nonprofit partners in our core business capabilities allows us to better understand the challenges faced by vulnerable communities, such as supply chain disruptions and resource constraints.” - Kyle Pudenz, SVP of Enterprise Analytics For more than a decade, the Cencora Impact Foundation, in partnership with Partners In Health (PIH), has been working to strengthen supply chains and support healthcare systems around the globe. Recently, lead pharmacists from PIH sites in Liberia, Sierra Leone, Malawi, Lesotho, and Rwanda gathered in Kigali, Rwanda for an intensive training program focused on overcoming systemic barriers to care. Cencora team members joined virtually to share global best practices and learn from the challenges these communities face. Learn more about Cencora’s impact: https://bit.ly/4qDWHyW
-
-
The Drug Supply Chain Security Act (DSCSA) final exemption deadline is on November 27, 2025. Join Gregg Gorniak, VP, Manufacturer Operations & Data Services at Cencora, for a 30-minute webinar designed to help dispensing entities understand the impact of the upcoming deadline, options to access serialized data and maintain compliance, and available resources to avoid disruptions. Can’t attend live? The webinar will be recorded and available on-demand. Register now: https://bit.ly/4i6rK2Q
-
-
Biosimilars continue to expand treatment access and reduce costs for patients and providers across the U.S. In a recent interview with Citeline, Dennis Nelson, Director of Biosimilar Commercialization at Cencora reflected on the current state of the U.S. biosimilars market, and the trends shaping its future. Read his perspective, including insights from Cencora’s experience supporting manufacturers to improve access to therapies like biosimilars and beyond: https://bit.ly/47G9Jol
-
"When community practices thrive, patients gain better access to care. As oncology continues to evolve and becomes increasingly complex, we're focused on partnering with practices by delivering the right solutions to expand patient access, and championing community oncology through policy advocacy." – Rich Tremonte, EVP and President, U.S. Pharmaceuticals and Animal Health
Our Fall 2025 Oncology Exchange meeting in Hollywood, Florida brought together leading voices in oncology and healthcare for a weekend of conversations to advance the dialogue on the future of cancer care. Thank you to our presenters, industry partners, and participants, all who helped make this event an incredible success. Mark your calendars for our 2026 Oncology Exchange events: • June 19-20, 2026 | Las Vegas, NV • October 2-3, 2026 | Orlando, FL
-
-
“Each year, we attend countless events, but few offer the level of connection with our pharmacy partners as our Health Systems National Summit. Being even a small part of their mission is what gets us up each morning.” - Beth Riggio, Vice President & General Manager – Practice Management Solutions Recently, partners from 56 health systems in the United States joined Cencora for our Health Systems National Summit to share insights, learn from one another, and advance our shared goal: expanding access to care and improving patient outcomes. Learn more about how we’re helping hospitals and health systems strengthen operations and enhance care: https://bit.ly/4nAc5cS
-
-
"During my time in the Navy, I learned that no matter how tough a problem is, there’s always a solution. You just have to keep pushing and work together to find it." - Phil Maniaci, Director of Operations and Membership Chair of Veterans in Action As an Operations Specialist in the Navy, Phil analyzed tactical data to help leaders make decisions under high pressure. Today, Phil applies the lessons and skills he learned to serving Cencora’s customers and their patients and our culture as the Membership Chair for our Veterans in Action employee resource group (ERG). Learn more about who we are and our culture: https://bit.ly/4nMB796
-
-
Every day, healthcare providers depend on Cencora to deliver the medications their patients need - quickly, safely, and reliably. To continue meeting that responsibility as the healthcare landscape evolves, Cencora is investing $1 billion through 2030 to strengthen our U.S. distribution network. From a new national distribution center in Ohio to an expanded presence in Alabama and California, we’re increasing capacity, speed, and cold chain capacity to meet the growing needs of our customers and the patients they serve. Read more on The Wall Street Journal: https://on.wsj.com/4nD3dTV
-
-
Distributors play a crucial role in the evolution of pharmaceutical supply chains, supporting the timely, safe, and compliant delivery of increasingly complex therapies. For Pharmaceutical Commerce, Heather Zenk, President of U.S. Supply Chain at Cencora, shares how smarter sourcing strategies, public-private collaboration, and advanced cold chain innovation are strengthening last-mile delivery and supporting access to care nationwide. Read Heather’s full perspective in this feature article: https://bit.ly/4oCVUg5
-
-
Cencora is investing $1 billion through 2030 to expand and strengthen our pharmaceutical distribution network in the United States. This investment reflects our commitment to build a more resilient and efficient supply chain: one that meets our customers’ growing needs and helps to ensure patients have timely and reliable access to their prescribed medications. By enhancing our infrastructure and digital capabilities, we’re positioning our customers — from pharmacies and health systems to specialty practices — to operate with greater confidence, agility, and access to the therapies their patients depend on. Read more about how these investments will come to life beginning today: https://bit.ly/43NLlhZ
-